Abuse of Gabapentin is Associated with Opioid Addiction (Q39989639)

16 September 2017

title

Abuse of Gabapentin is Associated with Opioid Addiction (English)

1 reference

16 September 2017

0 references

0 references

Leo Bastiaens

1 reference

16 September 2017

James Galus

series ordinal

1 reference

16 September 2017

Cherise Mazur

series ordinal

1 reference

16 September 2017

publication date

18 February 2016

1 reference

16 September 2017

published in

Psychiatric Quarterly

1 reference

16 September 2017

1 reference

16 September 2017

1 reference

16 September 2017

page(s)

763-767

1 reference

Subtypes of nonmedical prescription drug misuse

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Medical use, illicit use, and diversion of abusable prescription drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Abuse of combinations of gabapentin and quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Substance misuse of gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Gabapentin abuse in inmates with prior history of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Additional evidence of the abuse potential of bupropion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Bupropion diversion and misuse in the correctional facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Prescription medication misuse among opioid dependent patients seeking inpatient detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Treatment of alcohol withdrawal with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Placebo-controlled study of gabapentin treatment of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Treatment of social phobia with gabapentin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Gabapentin treatment for insomnia associated with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Gabapentin modifies extracellular opioid peptide content in amygdala: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

Neurocircuitry of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-016-9421-7

10.1007/S11126-016-9421-7

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference